Vertex의 비 오피오이드 진통제, 2025년 FDA 결정 예정

Category

인허가

Type

Submission

Official Announcement

https://news.vrtx.com/news-releases/news-release-details/vertex-announces-positive-results-vx-548-phase-3-program

BioSpace

https://www.biospace.com/drug-development/vertex-nabs-priority-review-for-non-opioid-pain-drug-awaits-january-2025-decision

Firstword

https://firstwordpharma.com/story/5880642

Release Date

2024/08/05

16 more properties

BioSpace

Firstword